Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3007821	p-glu/0	mmol/l (mmol/l)	1315	1834	0.00%
3007821	p-gluk-0h	mmol/l (mmol/l)	549	765	0.00%
3007821	p-gluk-0	mmol/l (mmol/l)	197	264	0.00%
3007821	p-gluk0	mmol/l (mmol/l)	168	192	0.00%
3007821	p-gluk0	— (—)	112	134	100.00%	Distribution not available
3007821	p-gluk0h	mmol/l (mmol/l)	61	69	0.00%
3007821	p-gluk-0	— (—)	26	26	100.00%	Distribution not available
3007821	p-glu/0	— (—)	25	25	100.00%	Distribution not available
3007821	p-glukoosi,0-näyte	mmol/l (mmol/l)	16	16	0.00%
3007821	p-gluk-0h	— (—)	10	10	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Persons with potential health hazards related to communicable diseases

705

881

8.17

307.65

1.5

1.4

5.26

5.40

mmol/l

1.58

694

824

Contact with and exposure to communicable diseases

674

747

9.32

307.65

1.5

1.4

5.21

5.32

mmol/l

1.06

664

698

Postpartum care and examination

289

146

13.00

225.97

1.5

1.3

4.92

5.59

mmol/l

7.78

284

140

Outcome of delivery

239

188

8.06

138.46

1.5

1.3

4.99

5.67

mmol/l

8.67

239

179

Other symptoms and signs involving the urinary system

132

171

7.92

95.70

1.3

5.90

5.96

mmol/l

0.11

132

160

Single delivery by forceps and vacuum extractor

125

119

6.42

60.31

1.7

1.3

4.93

5.83

mmol/l

7.72

119

113

Single delivery by caesarean section

143

158

5.26

56.18

1.5

1.3

5.03

5.92

mmol/l

9.10

135

150

Diabetes mellitus in pregnancy

297

721

2.66

47.73

1.8

1.3

5.35

5.07

mmol/l

2.99

279

696

Maternal care for other known or suspected fetal problems

207

444

2.98

40.73

1.8

1.4

4.91

5.22

mmol/l

5.12

200

423

Persons encountering health services for other counselling and medical advice, not elsewhere classified

555

1571

1.93

40.45

1.3

1.4

5.66

5.62

mmol/l

0.35

524

1484

Other maternal disorders predominantly related to pregnancy

385

1134

2.14

38.58

1.7

1.3

5.37

5.38

mmol/l

0.02

364

1077

Single spontaneous delivery

191

350

2.91

34.18

1.6

1.3

5.15

6.00

mmol/l

15.47

183

328

Delivery

191

350

2.90

33.92

1.5

1.3

5.16

6.00

mmol/l

15.06

182

328

Persons encountering health services in other circumstances, wide

554

1572

1.82

33.66

1.3

1.4

5.63

5.62

mmol/l

0.11

522

1485

False labour

218

545

2.51

31.36

1.6

1.4

5.10

5.33

mmol/l

1.54

213

519

Delivery, wide proxy

154

263

3.13

31.11

1.6

1.3

5.09

6.06

mmol/l

16.76

148

244

Type 2 diabetes, definitions combined, including avohilmo

447

1431

1.82

28.36

1.4

1.3

6.41

5.40

mmol/l

48.31

404

1372

Labour and delivery complicated by fetal stress [distress]

197

526

2.47

27.84

1.6

1.4

5.03

5.08

mmol/l

0.33

187

505

Other nutritional deficiencies

355

1805

1.86

26.31

1.6

1.3

5.65

5.50

mmol/l

1.52

336

1713

Maternal care for known or suspected abnormality of pelvic organs

184

514

2.46

25.96

1.7

1.4

5.10

5.36

mmol/l

2.27

171

486

Other obstetric conditions, not elsewhere classified

271

832

2.09

25.74

1.6

1.5

4.98

5.10

mmol/l

0.80

263

796

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

267

815

2.10

25.63

1.6

1.5

4.98

5.08

mmol/l

0.55

261

779

Obesity due to excess calories

269

1345

2.01

25.41

1.6

1.4

5.64

5.50

mmol/l

1.09

252

1273

Obstructed labour due to malposition and malpresentation of fetus

165

634

2.45

24.86

1.6

1.4

5.05

5.26

mmol/l

2.73

159

607

Obesity and other hyperalimentation

338

1768

1.85

24.77

1.6

1.4

5.66

5.50

mmol/l

1.68

318

1680

Obesity

337

1764

1.85

24.76

1.6

1.4

5.66

5.50

mmol/l

1.70

317

1676

Supervision of high-risk pregnancy

124

250

3.01

24.64

1.6

1.3

5.17

5.71

mmol/l

5.69

118

238

General examination and investigation of persons without complaint and reported diagnosis

316

843

1.96

24.35

1.3

1.4

5.60

5.54

mmol/l

0.32

295

795

Care involving use of rehabilitation procedures

286

1408

1.87

21.81

1.3

5.95

5.70

mmol/l

1.90

273

1324

Endocrine, nutritional and metabolic diseases

391

1125

1.76

21.70

1.5

1.3

5.70

5.19

mmol/l

7.16

366

1076

Perineal laceration during delivery

141

481

2.48

21.31

1.6

1.4

5.02

5.00

mmol/l

0.05

133

459

Antenatal screening

129

272

2.68

20.61

1.5

1.3

5.11

5.74

mmol/l

6.43

124

260

Other special examinations and investigations of persons without complaint or reported diagnosis

309

843

1.86

20.36

1.4

5.70

5.54

mmol/l

1.41

296

795

Type 2 diabetes, strict (exclude DM1)

414

1463

1.67

19.45

1.4

1.3

6.43

5.45

mmol/l

40.62

376

1397

Type 2 diabetes, definitions combined

412

1457

1.66

19.30

1.4

1.3

6.43

5.45

mmol/l

40.55

374

1392

Disorders of lipoprotein metabolism and other lipidaemias

310

1075

1.79

19.03

1.3

6.10

5.91

mmol/l

1.66

285

1016

Excessive earwax

212

1061

1.96

18.68

1.3

5.92

5.82

mmol/l

0.72

206

995

Maternal care related to the fetus and amniotic cavity and possible delivery problems

249

772

1.90

18.19

1.6

1.3

5.10

5.51

mmol/l

9.35

239

731

Presence of other devices

104

403

2.58

18.04

1.3

5.98

6.00

mmol/l

0.06

379

Complications of labour and delivery

323

1029

1.75

17.99

1.5

1.3

5.31

5.47

mmol/l

1.64

305

972

Maternal care for known or suspected malpresentation of fetus

132

404

2.39

17.97

1.6

1.4

5.04

5.20

mmol/l

0.49

125

383

Other diseases of hard tissues of teeth

229

619

1.92

16.75

1.3

5.90

5.71

mmol/l

0.86

217

590

Hyperlipidaemia, other/unspecified

134

567

2.18

15.78

1.3

1.2

6.27

6.10

mmol/l

0.62

125

536

Long labour

151

620

2.10

15.78

1.7

1.4

5.17

5.24

mmol/l

0.38

145

592

Maternal care for other conditions predominantly related to pregnancy

142

665

2.11

15.42

1.7

1.3

5.06

5.07

mmol/l

0.06

130

637

Episodal and paroxysmal disorders

482

1619

1.52

15.08

1.3

1.4

5.69

5.49

mmol/l

2.45

455

1532

Covid-19 confirmed case

163

831

1.97

14.82

1.5

1.4

5.44

5.72

mmol/l

2.28

157

785

Speech therapy

116

520

2.24

14.82

1.2

1.3

6.13

5.88

mmol/l

0.83

110

490

Supervision of normal pregnancy

111

264

2.41

14.69

1.6

1.3

5.02

5.70

mmol/l

9.44

104

252

Gestational diabetes (for exclusion)

258

1046

1.72

14.38

1.7

1.4

5.43

5.09

mmol/l

5.47

239

1010

Type 2 diabetes

413

1577

1.53

13.98

1.4

1.3

6.55

5.40

mmol/l

29.66

374

1508

Sleep apnoea, including avohilmo

381

1519

1.56

13.96

1.3

5.91

5.72

mmol/l

2.57

359

1432

Disease of hard tissues of teeth, NOS

212

610

1.82

13.45

1.3

6.08

5.71

mmol/l

1.78

202

581

Headache

315

1586

1.59

13.28

1.4

5.50

5.54

mmol/l

0.26

298

1505

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

265

1401

1.65

13.15

1.4

5.38

5.36

mmol/l

0.15

253

1325

Pure hypercholesterolaemia

245

944

1.70

12.87

1.3

6.08

5.96

mmol/l

0.94

231

892

Insulin, intermediate and long-acting

1173

0.31

12.79

1.3

9.15

5.78

mmol/l

3.25

1104

Dental operations

222

652

1.75

12.39

1.3

5.98

5.80

mmol/l

0.75

207

627

Abnormal findings on antenatal screening of mother

323

2.44

12.10

1.7

1.4

5.03

4.83

mmol/l

1.35

312

Diseases of pulp and periapical tissues and dental caries

243

739

1.69

11.90

1.3

5.85

5.65

mmol/l

0.98

230

706

Fitting and adjustment of other devices

119

529

2.04

11.82

1.4

1.3

5.94

6.00

mmol/l

0.21

111

494

Dental caries, including avohilmo

266

830

1.64

11.77

1.4

1.3

5.82

5.66

mmol/l

0.77

253

792

Gestational [pregnancy-induced] hypertension

166

920

1.81

11.74

1.4

1.5

5.35

5.24

mmol/l

0.64

159

877

Other disorders of amniotic fluid and membranes

381

2.27

11.62

1.5

1.4

4.92

5.16

mmol/l

2.75

362

Other dorsopathies, not elsewhere classified

436

1566

1.46

11.51

1.4

5.59

5.50

mmol/l

0.83

410

1481

Pregnancy hypertension

241

1331

1.63

11.46

1.4

5.37

5.34

mmol/l

0.20

229

1265

Caries of dentine, including avohilmo

290

934

1.59

11.28

1.4

1.3

5.80

5.63

mmol/l

0.90

275

888

Diseases of oral cavity, salivary glands and jaws

208

619

1.73

11.21

1.3

5.96

5.71

mmol/l

1.13

196

590

Hypertension, essential

282

1010

1.58

11.06

1.3

6.10

5.65

mmol/l

6.46

270

951

Diabetes, varying definitions

418

1695

1.45

10.89

1.4

1.3

6.55

5.35

mmol/l

27.18

380

1619

Persons encountering health services in circumstances related to reproduction

199

787

1.71

10.84

1.4

1.2

5.41

5.96

mmol/l

9.71

192

734

Type of accident

125

656

1.91

10.61

1.4

5.52

5.63

mmol/l

0.51

120

622

Diabetes mellitus

419

1705

1.44

10.56

1.4

1.3

6.55

5.35

mmol/l

27.45

380

1628

Dorsopathies

438

1571

1.42

9.99

1.4

5.58

5.50

mmol/l

0.70

413

1485

Transient ischemic attack

158

732

1.75

9.80

1.2

1.3

5.94

6.08

mmol/l

0.98

146

692

Insulin, combination of fast acting with intermediate-acting or long-acting

1298

0.45

9.70

1.4

1.3

7.82

5.73

mmol/l

3.33

1226

Other (not insulin) diabetes medications

375

1547

1.44

9.59

1.4

1.3

6.55

5.47

mmol/l

25.77

341

1473

Persons encountering health services for specific procedures and health care

434

1861

1.40

9.52

1.3

1.4

5.84

5.51

mmol/l

4.65

411

1757

Neurological diseases

379

1322

1.44

9.46

1.4

5.59

5.43

mmol/l

1.47

355

1255

Gingivitis and periodontal diseases

390

1407

1.43

9.42

1.3

5.74

5.62

mmol/l

1.18

357

1352

Sleep apnoea

322

1417

1.47

9.42

1.3

5.96

5.79

mmol/l

1.99

300

1337

Mouth breathing

142

806

1.76

9.38

1.2

1.3

5.88

5.86

mmol/l

0.10

132

765

Hypertension

281

1044

1.52

9.35

1.3

6.07

5.63

mmol/l

6.39

270

982

Hypertensive diseases

281

1046

1.52

9.28

1.3

6.07

5.63

mmol/l

6.43

270

984

Supplementary factors related to causes of morbidity and mortality classified elsewhere

130

728

1.79

9.06

1.4

5.53

5.62

mmol/l

0.41

124

690

Parasetamol

328

1138

1.46

8.85

1.4

5.51

5.44

mmol/l

0.42

307

1084

Ischaemic heart disease, wide definition

235

941

1.55

8.69

1.2

1.3

6.06

6.05

mmol/l

0.04

215

889

Dorsalgia

407

1565

1.40

8.61

1.4

5.58

5.50

mmol/l

0.74

376

1480

Haemorrhage in early pregnancy

139

789

1.72

8.43

1.5

1.3

5.30

5.29

mmol/l

0.03

131

757

Persons encountering health services in other circumstances

162

981

1.65

8.37

1.4

5.42

5.53

mmol/l

0.65

149

931

Biguanides

352

1527

1.41

8.06

1.4

1.3

6.66

5.51

mmol/l

22.62

320

1453

Angina pectoris

164

663

1.65

8.04

1.3

6.16

6.13

mmol/l

0.11

151

631

General symptoms and signs

450

1662

1.36

8.03

1.4

5.62

5.56

mmol/l

0.47

418

1576

Insulin medication

1112

0.48

8.01

1.4

1.3

7.82

5.52

mmol/l

3.88

1061

Spinal stenosis

147

664

1.68

7.96

1.3

1.2

6.15

6.10

mmol/l

0.16

138

618

Metabolic disorders

330

1426

1.41

7.79

1.3

6.02

5.71

mmol/l

3.89

309

1348

Persons encountering health services for examination and investigation

251

843

1.50

7.62

1.3

1.4

5.64

5.54

mmol/l

0.73

234

795

Symptoms and signs involving the circulatory and respiratory systems

426

1576

1.36

7.56

1.3

1.4

5.59

5.46

mmol/l

1.62

396

1509

Spondylosis

169

864

1.60

7.55

1.2

1.3

6.08

5.97

mmol/l

0.57

154

811

Symptoms and signs involving the urinary system

252

1312

1.47

7.51

1.3

5.95

5.77

mmol/l

1.26

246

1227

Covid-19 suspected case

626

0.29

7.43

1.4

4.98

5.42

mmol/l

1.50

593

Other symptoms and signs involving the digestive system and abdomen

364

2.01

7.34

1.2

1.4

5.54

5.76

mmol/l

1.20

346

Carpal tunnel syndrome

221

1313

1.49

7.24

1.4

1.3

5.81

5.77

mmol/l

0.23

200

1242

Contraceptive management

141

598

1.66

7.13

1.4

1.3

5.51

5.91

mmol/l

4.82

134

560

Thiazolidinediones

174

0.00

7.02

0.0

1.2

—

5.88

—

164

Spondylopathies

259

1071

1.45

6.96

1.2

1.3

6.01

5.81

mmol/l

1.51

239

1005

Caries of dentine

381

1.95

6.94

1.3

5.71

5.63

mmol/l

0.14

364

Rotator cuff syndrome

196

932

1.51

6.78

1.2

1.3

5.94

5.95

mmol/l

0.06

182

877

Other disorders of veins

951

0.45

6.75

1.3

5.96

5.84

mmol/l

0.22

893

STROKE

182

806

1.54

6.75

1.2

1.3

5.85

mmol/l

0.02

167

767

Preterm labour and delivery

115

683

1.69

6.65

1.5

1.3

5.34

5.51

mmol/l

1.14

108

646

Low back pain

297

1536

1.39

6.63

1.4

5.67

5.51

mmol/l

1.27

270

1452

Symptoms and signs involving the digestive system and abdomen

386

1440

1.34

6.57

1.3

1.4

5.69

5.59

mmol/l

0.85

361

1367

Obesity, other/unspecified

151

964

1.57

6.54

1.5

1.4

5.79

5.46

mmol/l

3.14

140

915

Depression

378

1920

1.34

6.50

1.4

5.64

5.55

mmol/l

0.59

359

1813

Abdominal and pelvic pain

384

1440

1.34

6.43

1.4

5.71

5.59

mmol/l

0.75

354

1367

Diabetic nephropathy, excluding more controls

286

0.23

6.41

1.1

1.4

7.64

6.59

mmol/l

—

258

Dental caries

449

1.82

6.40

1.3

5.75

5.64

mmol/l

0.22

429

Constipation

302

1522

1.37

6.30

1.3

5.94

5.74

mmol/l

1.80

286

1431

Mood disorders

396

1942

1.32

6.28

1.4

5.70

5.56

mmol/l

1.25

375

1834

Mood [affective] disorders

395

1941

1.32

6.25

1.4

5.70

5.56

mmol/l

1.20

374

1833

Obesity related asthma

127

788

1.62

6.23

1.4

1.3

5.84

5.80

mmol/l

0.21

118

743

Other neurological diseases

224

1224

1.44

6.22

1.3

5.83

5.84

mmol/l

0.02

209

1152

Lower back pain or/and sciatica

402

2006

1.31

6.05

1.3

1.4

5.65

5.57

mmol/l

0.61

368

1910

Pain in joint

225

1000

1.44

5.98

1.4

5.62

5.56

mmol/l

0.32

211

951

Gastrointestinal diseases

274

983

1.40

5.98

1.5

1.4

5.57

5.39

mmol/l

0.86

261

932

Hypertensive diseases (excluding secondary)

193

757

1.48

5.94

1.3

1.4

6.04

5.56

mmol/l

4.48

183

717

Spontaneous abortion

233

1107

1.42

5.91

1.5

1.4

5.40

5.37

mmol/l

0.15

223

1043

Ischemic heart diseases

253

1082

1.41

5.91

1.2

1.3

6.02

5.96

mmol/l

0.45

232

1026

Chronic periodontitis, including avohilmo

332

1662

1.34

5.89

1.3

5.89

5.71

mmol/l

1.81

305

1574

Periodontitis

333

1665

1.34

5.87

1.3

5.89

5.71

mmol/l

1.85

306

1577

Gonarthrosis,primary

261

1159

1.39

5.72

1.3

1.2

6.02

5.99

mmol/l

0.16

239

1096

Disorders of the thyroid gland

374

1859

1.31

5.70

1.4

5.64

5.53

mmol/l

0.84

348

1771

Abnormalities of breathing

358

1575

1.32

5.67

1.3

1.4

5.72

5.46

mmol/l

4.46

331

1509

Complications predominantly related to the puerperium

146

960

1.53

5.63

1.5

5.08

5.30

mmol/l

2.58

141

913

Diabetes medication

389

1772

1.30

5.58

1.5

1.3

6.59

5.38

mmol/l

25.34

355

1689

Caries of enamel

346

1899

1.32

5.51

1.4

5.49

5.58

mmol/l

0.50

318

1800

Diabetic nephropathy

310

0.25

5.46

1.1

1.4

7.64

6.66

mmol/l

—

282

Diseases of pulp and periapical tissues, including avohilmo

403

1612

1.30

5.44

1.4

5.75

5.50

mmol/l

2.17

376

1534

Other intervertebral disc disorders

297

1331

1.34

5.35

1.3

1.4

5.81

5.64

mmol/l

1.56

281

1251

Procreative management

461

1.69

5.30

1.6

1.3

5.33

5.92

mmol/l

5.66

439

Pre-eclampsia or poor fetal growth

167

1140

1.46

5.29

1.5

5.18

5.27

mmol/l

0.58

161

1087

Statin medication

231

928

1.40

5.29

1.3

1.4

6.13

5.48

mmol/l

5.09

212

882

Shoulder lesions

245

1074

1.38

5.28

1.3

5.98

5.85

mmol/l

0.73

227

1011

Diarrhoea and gastroenteritis of presumed infectious origin

382

1951

1.29

5.26

1.4

5.51

5.60

mmol/l

0.66

361

1846

Sleep disorders (combined)

430

1767

1.28

5.24

1.3

1.4

5.73

5.54

mmol/l

2.52

403

1677

Other obstructed labour

171

2.24

5.10

1.4

1.3

5.52

5.37

mmol/l

0.29

161

Gonarthrosis [arthrosis of knee](FG)

234

985

1.38

5.02

1.3

1.2

6.02

5.97

mmol/l

0.23

215

931

Other functional intestinal disorders

151

957

1.47

4.84

1.4

5.79

5.71

mmol/l

0.26

144

900

Pain (limb, back, neck, head abdominally)

272

1013

1.35

4.82

1.3

5.70

5.57

mmol/l

0.63

254

963

Other spirochaetal diseases

716

0.47

4.74

1.3

5.69

5.85

mmol/l

0.52

673

Umbilical hernia

552

1.63

4.74

1.4

1.3

5.69

5.76

mmol/l

0.25

522

Presence of cardiac and vascular implants and grafts

109

516

1.57

4.68

1.1

1.2

6.06

6.21

mmol/l

0.85

485

Asthma, including avohilmo

439

1968

1.25

4.68

1.4

5.64

5.56

mmol/l

0.81

415

1862

Lyme disease

709

0.48

4.63

1.3

5.69

5.85

mmol/l

0.53

666

Nerve, nerve root and plexus disorders

379

1827

1.27

4.62

1.4

1.3

5.76

5.62

mmol/l

1.67

353

1734

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

170

749

1.44

4.61

1.4

5.61

5.53

mmol/l

0.39

162

710

Cholecystectomy

237

1527

1.34

4.50

1.4

1.3

5.80

5.75

mmol/l

0.29

223

1435

Familial hypercholesterolemia, with ischemic heart disease

117

2.40

4.47

1.4

1.2

5.89

6.29

mmol/l

0.97

111

Migraine

222

1333

1.35

4.43

1.4

5.34

5.33

mmol/l

0.01

213

1268

Soft tissue disorders

395

1617

1.26

4.33

1.4

5.50

5.51

mmol/l

0.06

374

1531

Asthma, excluding more controls

296

1184

1.31

4.32

1.4

1.3

5.64

5.57

mmol/l

0.53

280

1129

Other and unspecified nonorganic psychotic disorders

459

1.66

4.29

1.3

1.4

6.18

5.40

mmol/l

4.11

434

Unspecified lump in breast

363

1.74

4.23

1.3

1.4

5.50

5.58

mmol/l

0.33

342

Rheumatism, unspecified

283

1.84

4.22

1.3

5.83

5.96

mmol/l

0.27

265

Lumbar disc prolapse

215

1224

1.35

4.22

1.3

1.4

5.76

5.69

mmol/l

0.49

204

1153

Spirochaetal infections, other/unspecified

711

0.51

4.21

1.3

5.65

5.85

mmol/l

0.77

668

Cholelithiasis, broad definition with cholecystitis

298

1555

1.29

4.21

1.3

5.87

5.69

mmol/l

1.76

281

1468

Mood disorders, excluding more controls

359

1697

1.26

4.20

1.4

5.72

5.54

mmol/l

1.71

338

1604

Disorders of gallbladder, biliary tract and pancreas

338

1681

1.27

4.13

1.3

5.88

5.68

mmol/l

2.28

316

1587

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

302

1415

1.29

4.10

1.4

1.3

6.93

5.47

mmol/l

22.69

273

1351

Hard cardiovascular diseases

248

1120

1.32

4.08

1.2

1.3

5.97

5.91

mmol/l

0.36

228

1067

Major coronary heart disease event

237

1077

1.33

4.07

1.2

1.3

5.99

mmol/l

0.01

216

1020

Asthma

300

1221

1.29

4.04

1.4

1.3

5.65

5.59

mmol/l

0.41

284

1162

Type 2 diabetes, wide definition

220

1053

1.34

4.01

1.3

6.81

5.64

mmol/l

17.29

198

1002

Hypothyroidism, other/unspecified

343

1791

1.26

4.01

1.3

1.4

5.63

5.52

mmol/l

0.93

316

1705

Triptan medication for migraine, single purchase ok

316

1684

1.27

4.00

1.4

5.42

5.50

mmol/l

0.39

300

1595

Migraine, single triptan purchase ok & required. ICD-code if available is included

316

1684

1.27

4.00

1.4

5.42

5.50

mmol/l

0.39

300

1595

Gonarthrosis

195

814

1.37

3.97

1.3

5.98

5.95

mmol/l

0.12

179

771

Pain in throat and chest

309

1454

1.28

3.97

1.2

1.4

5.82

5.52

mmol/l

4.34

285

1391

Other spirochaetal diseases

722

0.53

3.96

1.3

5.66

5.85

mmol/l

0.75

677

Other soft tissue disorders, not elsewhere classified

346

1611

1.26

3.95

1.4

5.63

5.51

mmol/l

1.23

327

1527

Hernia of abdominal wall

136

953

1.43

3.94

1.4

1.3

5.93

5.83

mmol/l

0.39

123

895

Diabetic neuropathy

211

0.23

3.93

1.2

1.3

6.28

6.68

mmol/l

—

191

Kela-code for severe mental illness

133

930

1.43

3.90

1.3

1.4

6.27

5.52

mmol/l

4.34

123

882

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

135

947

1.43

3.90

1.6

1.4

5.41

5.31

mmol/l

0.42

130

905

Asthma (mode)

295

1232

1.28

3.87

1.4

1.3

5.63

5.59

mmol/l

0.29

280

1172

Exclusions for E4_PCOS_CONSORTIUM

194

1624

0.75

3.86

1.3

1.4

5.65

5.43

mmol/l

2.52

184

1536

Cholelithiasis

285

1535

1.28

3.85

1.3

5.87

5.70

mmol/l

1.64

268

1449

Other acute lower respiratory infections

173

1208

1.37

3.84

1.3

1.4

5.55

5.66

mmol/l

0.58

165

1142

Diseases of oesophagus, stomach and duodenum

375

1806

1.24

3.83

1.3

1.4

5.88

5.59

mmol/l

2.95

359

1703

Sciatica+with lumbago

173

1169

1.36

3.77

1.3

1.4

5.55

5.68

mmol/l

1.00

159

1099

Asthma (only as main-diagnosis), excluding more controls

267

1184

1.29

3.72

1.4

1.3

5.62

5.57

mmol/l

0.30

250

1129

Coronary atherosclerosis

167

768

1.38

3.68

1.3

1.2

6.07

6.11

mmol/l

0.21

151

731

Schizophrenia or delusion

111

760

1.46

3.67

1.3

1.4

6.15

5.56

mmol/l

4.30

102

719

Pregnancy with abortive outcome

291

1191

1.28

3.66

1.5

1.4

5.32

5.38

mmol/l

0.46

275

1125

Excluding asthma or asthma-COPD overlap

311

1231

1.27

3.65

1.4

1.3

5.60

5.59

mmol/l

0.06

289

1171

Artrosis, including avohilmo

265

1126

1.29

3.64

1.3

5.84

5.73

mmol/l

0.55

243

1068

Coronary revascularization (ANGIO or CABG)

219

1017

1.32

3.64

1.2

1.3

6.02

5.99

mmol/l

0.13

198

963

Hernia of abdominal wall, postoperative

380

1.66

3.63

1.5

1.3

5.96

5.82

mmol/l

0.29

353

ILD differential diagnosis

311

1232

1.27

3.63

1.4

1.3

5.61

5.59

mmol/l

0.07

288

1172

COPD differential diagnosis

311

1233

1.26

3.61

1.4

1.3

5.61

5.59

mmol/l

0.08

288

1173

Gastro-oesophageal reflux disease

216

1424

1.31

3.60

1.3

5.91

5.74

mmol/l

0.77

205

1335

Asthma (only as main-diagnosis)

270

1221

1.28

3.58

1.4

1.3

5.62

5.59

mmol/l

0.19

253

1162

Other sexually transmitted chlamydial diseases

234

0.30

3.57

1.4

1.6

5.09

5.14

mmol/l

—

224

Diseases of the respiratory system

253

981

1.29

3.52

1.3

1.4

5.61

5.58

mmol/l

0.12

238

936

Other abnormal products of conception

178

874

1.35

3.52

1.5

1.4

5.15

5.23

mmol/l

0.53

171

834

Dependent personality disorder

3.92

3.50

1.1

1.4

5.56

6.42

mmol/l

0.61

Follow-up examination after treatment for conditions other than malignant neoplasms

161

779

1.37

3.48

1.4

5.37

5.49

mmol/l

0.83

153

735

Percutaneous Coronary Intervention

217

1016

1.31

3.46

1.2

1.3

6.02

5.99

mmol/l

0.12

196

962

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

135

966

1.40

3.45

1.6

1.5

5.41

5.22

mmol/l

1.13

130

924

Hypothyreosis and Thyroxine purchase for inclusion criteria

349

1858

1.23

3.43

1.3

1.4

5.64

5.53

mmol/l

0.87

320

1770

Diastasis of muscle

5.11

3.39

1.4

1.3

5.16

6.83

mmol/l

—

Exposure to unspecified factor

240

2197

0.78

3.39

1.3

1.4

5.80

5.56

mmol/l

1.33

224

2080

Leiomyoma of uterus

132

1036

0.72

3.35

1.3

5.93

5.64

mmol/l

2.45

124

970

Acute upper respiratory infections

371

1870

1.22

3.34

1.4

1.3

5.57

5.62

mmol/l

0.37

350

1767

Antihypertensive medication - note that there are other indications

267

1113

1.27

3.34

1.5

5.53

5.11

mmol/l

4.94

255

1061

Other diseases of upper respiratory tract

395

1691

1.22

3.33

1.3

1.4

5.65

5.61

mmol/l

0.23

373

1605

Other pulmonary diagnosis

307

1231

1.25

3.28

1.4

1.3

5.60

5.59

mmol/l

0.02

285

1171

Other symptoms and signs involving cognitive functions and awareness

125

816

1.40

3.22

1.2

1.3

5.77

5.95

mmol/l

1.36

116

773

Schizophrenia, schizotypal and delusional disorders

109

765

1.43

3.21

1.3

1.4

6.15

5.56

mmol/l

4.10

100

724

Symptoms and signs involving the skin and subcutaneous tissue

242

1876

1.26

3.15

1.4

5.63

5.62

mmol/l

0.07

228

1775

Emergency coronary revascularization (for ACS)

228

1081

1.28

3.14

1.2

1.3

6.04

6.00

mmol/l

0.21

206

1025

Varus deformity, not elsewhere classified

4.57

3.13

1.3

5.66

5.73

mmol/l

—

Schizophrenia or delusion, excluding more controls

111

778

1.42

3.12

1.3

1.4

6.15

5.48

mmol/l

5.42

102

739

Diabetes, insulin treatment (Kela reimbursement)

318

1559

1.23

3.12

1.4

1.3

6.96

5.53

mmol/l

22.08

288

1480

Meniscus derangement

168

851

1.33

3.09

1.3

6.03

5.90

mmol/l

0.34

155

810

Hypothyroidism (congenital or acquired)

138

568

1.38

3.02

1.3

1.5

5.43

4.96

mmol/l

4.76

125

548

Complications of anaesthesia during pregnancy

10.52

3.01

2.0

1.6

5.04

5.34

mmol/l

—

Other infestations

3.89

2.99

1.0

1.2

5.75

6.78

mmol/l

—

Other disorders of urethra and urinary system

262

1518

1.25

2.95

1.3

1.4

5.61

5.56

mmol/l

0.25

250

1438

Other female pelvic inflammatory diseases

427

1.55

2.94

1.2

1.4

5.36

5.54

mmol/l

0.87

400

Hypothyroidism, levothyroxine purchases

137

567

1.37

2.93

1.4

1.5

5.41

4.96

mmol/l

4.48

125

547

Hypothyroidism and >3 levothyroxin purchases

137

567

1.37

2.93

1.4

1.5

5.41

4.96

mmol/l

4.48

125

547

Other joint disorders

348

1512

1.21

2.92

1.4

5.53

5.46

mmol/l

0.35

328

1439

Other benign neoplasms of uterus

2.44

2.88

1.1

1.3

6.03

5.75

mmol/l

0.85

Exposure to other specified factors

172

2039

0.77

2.87

1.3

1.4

5.59

5.57

mmol/l

0.06

167

1928

Other diseases of urinary system

371

1738

1.20

2.80

1.4

5.49

5.57

mmol/l

0.75

352

1649

Mixed and other personality disorders

194

1.81

2.79

1.2

1.4

5.70

5.49

mmol/l

0.51

186

Other systemic involvement of connective tissue (FG)

587

1.45

2.79

1.3

1.4

5.43

5.78

mmol/l

2.75

558

Bronchitis

382

2016

1.19

2.78

1.4

5.48

5.60

mmol/l

1.12

358

1910

Medical abortion

270

1183

1.24

2.78

1.4

5.33

5.39

mmol/l

0.34

254

1117

Schizophrenia

315

1.62

2.77

1.3

1.4

6.42

5.70

mmol/l

2.76

299

Medical observation and evaluation for suspected diseases and conditions

210

843

1.28

2.73

1.3

1.4

5.74

5.54

mmol/l

1.56

193

795

Cystitis

331

1630

1.21

2.72

1.3

1.4

5.47

5.53

mmol/l

0.51

311

1547

Primary gonarthrosis, bilateral

125

792

1.35

2.70

1.3

1.2

5.97

6.10

mmol/l

0.68

114

744

310

1.62

2.69

1.5

1.4

5.31

5.48

mmol/l

0.67

296

Hypothyroidism, strict autoimmune

290

1565

1.22

2.67

1.3

1.4

5.63

5.47

mmol/l

1.50

266

1492

Any death

890

0.71

2.66

1.1

1.3

6.14

6.08

mmol/l

0.26

835

Type 1 diabetes, definitions combined

213

0.37

2.65

1.8

1.5

7.00

5.16

mmol/l

—

206

Hypothyroidism, strict autoimmune, 3 medication purchases required

319

1788

1.21

2.63

1.3

1.4

5.65

5.52

mmol/l

1.23

293

1701

Diverticular disease of intestine

192

962

1.28

2.62

1.2

5.92

6.02

mmol/l

0.64

182

902

Cerebrovascular diseases (FINNGEN)

441

1.43

2.60

1.3

5.86

5.80

mmol/l

0.23

420

Dental pulpitis, including avohilmo

347

1887

1.19

2.57

1.5

1.4

5.54

mmol/l

0.03

328

1785

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

135

1718

0.76

2.56

1.5

1.4

5.44

5.49

mmol/l

0.19

125

1625

Lower leg

5.56

2.56

1.3

1.2

5.68

6.19

mmol/l

—

404

1768

1.18

2.55

1.4

5.60

mmol/l

0.03

381

1671

Diseases of salivary glands

107

784

1.37

2.54

1.4

5.72

5.68

mmol/l

0.16

101

738

Fall on same level

314

2055

0.83

2.54

1.4

5.72

5.54

mmol/l

1.13

293

1948

Type 1 diabetes, strict (exclude DM2)

210

0.38

2.53

1.8

1.5

7.00

5.14

mmol/l

—

204

Bacterial infection, other or unspecified

159

1042

1.29

2.50

1.2

1.3

6.11

5.82

mmol/l

1.28

143

983

Intestinal infectious diseases

399

1936

1.18

2.49

1.3

1.4

5.62

5.61

mmol/l

0.03

373

1833

Postviral fatigue syndrome

3.88

2.48

1.3

1.6

5.02

5.43

mmol/l

—

Varicose veins

178

1057

1.27

2.47

1.3

1.2

5.77

5.96

mmol/l

1.70

167

988

Other diseases of oesophagus

151

1.86

2.46

1.2

1.3

5.74

5.95

mmol/l

1.15

143

Other benign neoplasm of uterus: Corpus uteri

5.08

2.41

1.0

1.2

6.32

5.49

mmol/l

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

148

567

1.31

2.40

1.4

5.52

5.38

mmol/l

0.84

142

546

Enthesopathies of lower limb, excluding foot

481

1.46

2.40

1.3

5.58

5.77

mmol/l

0.93

454

Congenital varicose veins

6.39

2.38

1.8

1.1

5.37

5.80

mmol/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

349

0.50

2.35

1.4

5.38

5.57

mmol/l

0.41

331

COPD/asthma related infections

382

1625

1.18

2.35

1.4

5.61

5.57

mmol/l

0.29

362

1542

COPD/asthma/ILD related infections

382

1625

1.18

2.35

1.4

5.61

5.57

mmol/l

0.29

362

1542

Acute bronchitis

122

906

1.32

2.34

1.3

1.4

5.55

5.70

mmol/l

0.99

116

851

Inflammatory diseases of female pelvic organs

262

1592

1.21

2.33

1.4

5.38

mmol/l

0.03

246

1511

Abnormalities of heart beat

113

831

1.33

2.33

1.3

1.4

5.65

5.61

mmol/l

0.18

103

798

Arthrosis

213

942

1.24

2.31

1.3

5.83

5.84

mmol/l

0.07

196

894

Acetic acid derivatives and related substances

373

1.38

2.28

1.3

1.4

5.79

5.38

mmol/l

0.94

356

Provisional assignment of new diseases of uncertain etiology

180

1438

1.25

2.27

1.5

1.4

5.42

5.55

mmol/l

0.84

169

1363

Codes for special purposes

180

1441

1.25

2.24

1.5

1.4

5.42

5.54

mmol/l

0.84

169

1365

Diseases of the musculoskeletal system and connective tissue

223

908

1.23

2.24

1.4

5.51

5.39

mmol/l

0.45

212

862

Allergic conjunctivitis

145

1795

0.79

2.23

1.5

1.4

5.47

5.48

mmol/l

0.05

135

1700

Hand

5.66

2.22

1.8

1.1

4.92

8.30

mmol/l

—

Other arthrosis

144

775

1.29

2.21

1.3

1.2

5.90

5.98

mmol/l

0.44

136

737

Other diseases of anus and rectum

581

1.39

2.20

1.3

5.81

5.92

mmol/l

0.45

550

Other congenital malformations of peripheral vascular system

3.37

2.19

1.9

1.4

5.38

6.47

mmol/l

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

341

1889

1.18

2.18

1.3

1.4

5.76

5.56

mmol/l

2.41

315

1792

Cardiovascular diseases

267

1193

1.20

2.16

1.5

5.32

5.23

mmol/l

0.81

254

1136

Gout, idiopatic and unspecified

345

1.51

2.15

1.2

6.24

6.19

mmol/l

0.09

322

Triptan medication for migraine, min. 3 purchases

245

1551

1.21

2.15

1.4

5.37

5.38

mmol/l

0.04

230

1479

Excessive, frequent and irregular menstruation

195

863

1.24

2.11

1.4

1.5

5.41

5.20

mmol/l

1.84

181

832

Superficial injury of wrist and hand

520

1.41

2.11

1.4

1.5

5.36

5.42

mmol/l

0.20

497

Thyrotoxicosis with toxic multinodular goitre

2.01

2.10

1.3

1.4

6.01

5.96

mmol/l

0.04

Poisoning by medicine, drug-induced

3.23

2.10

1.4

1.3

6.03

6.67

mmol/l

—

Chronic lower respiratory diseases

427

1971

1.15

2.10

1.4

5.64

5.56

mmol/l

0.92

404

1864

Complications following infusion, transfusion and therapeutic injection

3.53

2.06

1.4

1.2

5.28

7.18

mmol/l

—

Systemic connective tissue disorders

106

805

1.32

2.06

1.3

5.50

5.76

mmol/l

1.97

101

756

Neurological diseases, wide definition

126

485

1.31

2.05

1.4

1.5

5.35

5.04

mmol/l

3.49

119

468

Arthropathies

349

1512

1.17

2.04

1.4

5.47

5.46

mmol/l

0.04

325

1439

Amenorrhoea

314

0.51

2.03

1.5

1.6

5.20

5.02

mmol/l

0.46

306

Acute nasopharyngitis (common cold)

206

1.64

2.02

1.2

1.4

5.50

5.77

mmol/l

0.71

198

Persons encountering health services for specific procedures, not carried out

161

0.37

2.01

1.3

1.4

5.23

5.61

mmol/l

—

155

Gout

345

1.46

1.97

1.2

6.23

mmol/l

0.00

326

Rheumatoid arthritis, including avohilmo

894

0.71

1.96

1.3

5.70

5.83

mmol/l

0.34

844

Unspecified mental disorder

137

1084

1.27

1.96

1.3

1.4

6.22

5.49

mmol/l

4.35

127

1027

Dermatophytosis

189

1549

1.22

1.95

1.4

5.73

5.68

mmol/l

0.24

180

1468

Convergence insufficiency and excess

2.76

1.94

2.1

1.4

4.88

5.22

mmol/l

—

Other and unspecified tonsillitis

142

948

1.26

1.93

1.5

5.40

5.28

mmol/l

0.40

135

909

Asthma, hospital admissions , main diagnosis only

277

2078

1.18

1.91

1.4

5.62

5.56

mmol/l

0.49

260

1970

Other systemic involvement of connective tissue

642

1.34

1.90

1.3

5.43

5.76

mmol/l

2.60

603

Polycystic ovarian syndrome, consortium definition

307

1554

1.17

1.90

1.4

5.66

5.32

mmol/l

5.98

286

1477

Carcinoma in situ of other and unspecified digestive organs

0.00

1.89

0.0

1.2

—

6.54

—

Chronic apical periodontitis

392

1943

1.15

1.88

1.3

1.4

5.73

5.54

mmol/l

2.40

363

1850

Spirochaetal infections, other/unspecified

157

0.38

1.88

1.2

1.3

5.19

5.92

mmol/l

—

149

Zoster [herpes zoster]

136

1066

1.26

1.86

1.3

5.70

5.81

mmol/l

0.53

128

1001

Acute upper respiratory infections of multiple and unspecified sites

265

1666

1.18

1.85

1.4

5.37

5.57

mmol/l

2.38

246

1583

Injury, poisoning and certain other consequences of external causes

220

915

1.21

1.85

1.4

5.62

5.47

mmol/l

0.61

209

864

Malignant neoplasm of breast, including Hilmo

754

0.75

1.85

1.2

1.3

5.83

5.75

mmol/l

0.31

712

Malignant neoplasm of breast, HER2-negative, including Hilmo

754

0.75

1.85

1.2

1.3

5.83

5.75

mmol/l

0.31

712

Pain in limb

277

1578

1.17

1.83

1.4

5.62

5.52

mmol/l

0.80

258

1495

Disorders of synovium and tendon

173

1240

1.22

1.82

1.3

1.4

5.60

5.65

mmol/l

0.34

166

1172

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

3.07

1.80

1.6

1.4

6.16

6.74

mmol/l

—

Chronic periodontitis, complicated

143

1141

1.24

1.79

1.3

5.94

5.93

mmol/l

0.03

133

1073

Used for control exclusion in common control thyroid runs

378

1666

1.15

1.75

1.4

5.75

5.50

mmol/l

1.89

352

1588

Wet age-related macular degeneration

218

1.56

1.72

1.3

1.2

6.19

6.29

mmol/l

0.14

203

Lung diseases due to external agents

217

0.46

1.72

1.2

1.3

5.81

6.08

mmol/l

—

203

Asthma (diagnoses ohter than nonallergic)

291

2082

1.16

1.70

1.3

1.4

5.63

5.57

mmol/l

0.49

276

1970

Excessive vomiting in pregnancy

226

1.55

1.70

1.4

5.45

5.13

mmol/l

0.26

213

Bacterial infection, other or unspecified

136

950

1.24

1.69

1.2

1.3

6.16

5.85

mmol/l

1.58

123

896

Cervicobrachial syndrome

501

1.36

1.67

1.3

5.61

5.73

mmol/l

0.43

473

Postmenopausal bleeding

254

1.39

1.67

1.3

6.03

5.99

mmol/l

0.08

240

Symptoms and signs involving the nervous and musculoskeletal systems

173

1433

1.21

1.67

1.4

1.3

5.82

5.70

mmol/l

0.83

151

1363

Malignant neoplasm of breast

739

0.77

1.66

1.2

1.3

5.85

5.76

mmol/l

0.32

697

Parapsoriasis

2.60

1.66

1.3

1.4

6.00

6.37

mmol/l

—

Foreign body in ear

2.60

1.66

1.8

1.4

5.60

6.37

mmol/l

—

Other specific joint derangements/joint disorders

270

1499

1.16

1.63

1.4

5.59

5.45

mmol/l

1.28

254

1429

Gout due to impairment of renal function

3.60

1.62

1.0

1.2

6.02

7.77

mmol/l

—

Other disorders of eyelid

107

804

1.27

1.61

1.4

1.3

5.94

5.97

mmol/l

0.09

753

Explicit bacterial Sepsis

189

0.48

1.60

1.4

6.67

5.86

mmol/l

—

180

Hernia

278

1609

1.16

1.58

1.3

5.86

5.73

mmol/l

1.02

261

1517

Other enthesopathies

680

1.30

1.58

1.4

1.3

5.89

5.83

mmol/l

0.21

645

Benign neoplasm: Other and unspecified parts of small intestine

3.02

1.58

1.3

1.1

5.97

6.97

mmol/l

—

Disorders of choroid and retina

152

1310

0.82

1.58

1.2

1.3

6.00

5.88

mmol/l

0.50

144

1224

Female genital prolapse

415

1.30

1.57

1.3

1.4

5.85

5.60

mmol/l

0.61

396

Asthma, unspecified (mode), excluding more controls

173

1077

1.20

1.56

1.2

1.3

5.70

5.62

mmol/l

0.53

160

1027

Autoimmune diseases excluding thyroid diseases

280

1763

0.87

1.56

1.4

5.87

5.53

mmol/l

2.03

262

1678

Major coronary heart disease event excluding revascularizations

130

699

1.24

1.55

1.2

1.3

6.11

6.13

mmol/l

0.07

115

667

Other diseases of intestines

373

1870

1.13

1.55

1.3

1.4

5.67

5.52

mmol/l

1.36

354

1771

Fentanyl

156

0.45

1.54

1.3

1.2

6.46

6.15

mmol/l

—

149

Unspecified haematuria

594

1.28

1.53

1.2

1.3

5.99

mmol/l

0.00

553

Previous suicide attempt

2.88

1.51

1.2

1.3

5.33

6.67

mmol/l

—

Asthma/COPD (KELA code 203)

327

1969

1.14

1.49

1.4

5.61

5.56

mmol/l

0.51

311

1862

Malignant neoplasm of breast, HER2-negative

729

0.78

1.49

1.2

1.3

5.86

5.77

mmol/l

0.33

687

Volume depletion

131

1.68

1.49

1.4

1.3

6.25

6.08

mmol/l

0.20

126

Other/unspecified dorsalgia

113

901

1.24

1.49

1.4

5.75

5.64

mmol/l

0.55

107

853

Other heart diseases

150

807

1.21

1.48

1.3

1.4

5.67

5.51

mmol/l

1.09

144

768

Anxiety (asthma-related co-morbidities)

226

1499

1.17

1.47

1.5

1.4

5.62

5.42

mmol/l

1.23

219

1423

Cough

116

886

1.24

1.47

1.3

1.4

5.71

5.67

mmol/l

0.17

107

846

Localized swelling, mass and lump of skin and subcutaneous tissue

733

1.27

1.46

1.3

5.81

5.78

mmol/l

0.11

690

Chronic diseases of tonsils and adenoids

283

1558

1.15

1.45

1.4

5.42

5.55

mmol/l

1.21

263

1479

Fissure and fistula of anal and rectal regions

523

1.32

1.45

1.5

1.3

5.81

5.82

mmol/l

0.03

493

Sequelae of cerebrovascular disease

502

0.70

1.45

1.3

1.2

6.22

6.14

mmol/l

0.12

472

Tonsillectomy and adenotomy

222

1324

1.17

1.44

1.5

1.4

5.31

5.33

mmol/l

0.05

208

1265

Gout, FINNGEN

419

1.36

1.44

1.2

6.23

6.26

mmol/l

0.05

393

HSIL lesion of the vagina

2.75

1.44

1.2

1.4

5.42

5.49

mmol/l

—

Menorrhagia

150

688

1.21

1.42

1.4

1.5

5.48

5.30

mmol/l

1.61

143

662

Diseases of arteries, arterioles and capillaries (FINNGEN)

272

1.38

1.40

1.3

1.2

6.31

6.02

mmol/l

0.76

260

Other and unspecified disorders of vitreous body

102

806

1.25

1.40

1.3

5.90

6.04

mmol/l

0.84

750

Periapical abscess

130

1070

1.22

1.40

1.3

5.67

5.78

mmol/l

0.64

118

1010

Finngen Rheumatological endpoints

337

1693

1.13

1.40

1.3

1.4

5.61

5.53

mmol/l

0.72

316

1611

Pleural plaque

139

0.43

1.39

1.3

1.2

5.77

6.39

mmol/l

—

132

Other chronic obstructive pulmonary disease, including avohilmo

117

786

1.23

1.38

1.3

1.2

6.11

6.10

mmol/l

0.03

111

738

Other symptoms and signs involving the nervous and musculoskeletal systems

131

1081

1.21

1.38

1.4

5.74

5.64

mmol/l

0.62

114

1029

Disturbances of skin sensation

101

811

1.25

1.38

1.4

5.44

5.53

mmol/l

0.43

772

Asthma, unspecified (mode)

174

1107

1.18

1.37

1.2

1.3

5.71

5.64

mmol/l

0.49

161

1054

Other bacterial diseases

314

1756

1.13

1.37

1.3

1.4

5.97

5.62

mmol/l

3.78

291

1660

Cardiac arrhythmias

202

1121

1.17

1.37

1.3

1.4

5.63

5.30

mmol/l

4.61

197

1074

Faecal incontinence

158

1.59

1.37

1.3

5.72

5.96

mmol/l

0.54

150

Assault by blunt object

2.63

1.37

1.0

1.3

5.68

6.76

mmol/l

—

Any reimbursement code in KELA

253

1099

1.15

1.36

1.5

1.4

5.68

5.15

mmol/l

4.14

238

1059

Ankle and foot

2.97

1.36

1.8

1.2

5.54

7.14

mmol/l

—

Acquired absence of limb

2.97

1.36

1.0

1.2

7.28

7.30

mmol/l

—

Melanoma in situ of trunk

2.96

1.36

1.6

1.1

5.94

7.56

mmol/l

—

Recurrent or chronic depression

158

931

1.19

1.36

1.3

1.4

5.69

5.42

mmol/l

1.21

148

885

Soft tissue disorders related to use, overuse and pressure

538

1.30

1.35

1.2

1.3

5.90

5.93

mmol/l

0.08

504

Contact with sharp object, undetermined intent

0.00

1.34

0.0

1.5

—

6.20

—

Premature separation of placenta [abruptio placentae]

2.05

1.33

1.7

1.4

4.77

5.50

mmol/l

2.69

Ulcer of lower limb, not elsewhere classified

221

0.54

1.32

1.1

1.3

7.07

6.09

mmol/l

0.51

207

Any event in cancer register

251

1690

0.87

1.30

1.3

1.4

5.82

5.58

mmol/l

3.11

239

1596

Thyroiditis, ILD-related definition

309

1.39

1.29

1.3

1.4

5.22

5.49

mmol/l

1.03

295

Autoimmune diseases excluding thyroid diseases, strict definition

276

1717

0.88

1.29

1.4

5.89

5.51

mmol/l

2.19

257

1639

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

119

1435

0.83

1.28

1.3

1.4

5.92

5.73

mmol/l

0.60

112

1349

Cardiovascular diseases (excluding rheumatic etc)

251

1261

1.15

1.26

1.4

1.5

5.51

5.27

mmol/l

2.84

239

1199

Haemorrhoids and perianal venous thrombosis

640

1.26

1.2

1.3

5.84

5.92

mmol/l

0.21

603

Disorders of breast

182

1419

1.17

1.24

1.4

5.43

5.48

mmol/l

0.29

172

1341

Other disorders of choroid

2.65

1.22

1.0

1.3

5.68

7.21

mmol/l

—

Marginal zone B-cell lymphoma, including Hilmo

2.65

1.22

1.4

1.1

5.30

7.10

mmol/l

—

Behavioural syndromes associated with physiological disturbances and physical factors

312

1970

1.12

1.21

1.3

1.4

5.51

5.57

mmol/l

0.39

293

1866

Benign neoplasm: Duodenum

2.17

1.21

1.6

1.2

6.25

6.52

mmol/l

—

Diseases of the eye and adnexa

320

1427

1.12

1.19

1.4

5.60

5.44

mmol/l

0.79

303

1351

Oral corticosteroids

358

1906

1.11

1.19

1.3

1.4

5.70

5.59

mmol/l

0.96

334

1809

Erectile dysfunction

109

1.66

1.18

1.2

6.18

6.37

mmol/l

0.31

103

Diseases of inner ear

137

1117

1.19

1.18

1.3

5.81

5.88

mmol/l

0.47

127

1052

Unstable angina pectoris

446

1.27

1.18

1.2

6.21

6.19

mmol/l

0.04

425

All anxiety disorders

232

1608

1.14

1.17

1.5

1.4

5.59

5.42

mmol/l

0.95

225

1520

Chronic suppurative otitis media, including avohilmo

141

1.56

1.17

1.3

1.4

6.28

5.75

mmol/l

0.73

135

Assault by other specified means

2.52

1.15

1.2

1.3

5.92

6.49

mmol/l

—

Benign neoplasm: Connective and other soft tissue, unspecified

2.52

1.15

1.2

5.71

6.84

mmol/l

—

Other retinal disorders

110

1031

0.83

1.15

1.3

6.06

5.92

mmol/l

0.46

104

968

Erysipelas

185

1221

1.16

1.15

1.2

1.3

6.09

5.83

mmol/l

1.70

176

1151

Duodenal ulcer

154

0.52

1.13

1.1

1.2

7.33

6.04

mmol/l

—

144

Sleep disorders

300

1938

1.12

1.3

1.4

5.49

5.56

mmol/l

0.43

284

1836

Nonspecific lymphadenitis

119

1.60

1.11

1.2

1.4

5.65

5.78

mmol/l

0.14

114

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

151

1.53

1.11

1.3

1.4

5.96

5.84

mmol/l

0.16

143

Other specified/unspecified spondylopathies

2.27

1.10

1.0

1.3

5.33

6.62

mmol/l

—

Synovial hypertrophy, not elsewhere classified

2.40

1.09

1.0

1.4

5.30

6.73

mmol/l

—

Other lack of coordination

2.39

1.09

2.0

1.1

6.20

7.20

mmol/l

—

Macular pucker

268

0.63

1.08

1.1

1.2

5.70

6.20

mmol/l

2.22

248

Hallux rigidus

255

0.63

1.07

1.1

1.2

6.27

6.09

mmol/l

0.33

242

Family history of other conditions

2.13

1.06

1.1

1.5

6.04

5.98

mmol/l

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

760

0.81

1.05

1.2

7.43

5.83

mmol/l

6.10

719

Other fall from one level to another

515

1.26

1.05

1.3

1.4

5.57

mmol/l

0.00

490

Trochanteric bursitis

262

1.38

1.05

1.2

1.3

5.88

6.06

mmol/l

0.35

245

Injury of muscle and tendon at shoulder and upper arm level

632

1.24

1.04

1.2

1.3

5.99

6.06

mmol/l

0.25

592

Diseases of the ear and mastoid process

405

1851

1.10

1.03

1.4

5.55

mmol/l

0.02

379

1757

Burn and corrosion of ankle and foot

2.28

1.03

1.2

5.15

6.88

mmol/l

—

Guttate psoriasis

2.28

1.03

1.2

1.4

5.46

6.48

mmol/l

—

Myasthenia gravis

2.28

1.03

1.6

1.2

5.16

6.87

mmol/l

—

Streptococcal septicaemia

147

0.54

1.03

1.3

6.84

5.95

mmol/l

—

138

Abrasion of teeth

102

851

1.20

1.03

1.2

1.3

5.80

5.72

mmol/l

0.12

803

Asthma-related infections

173

1476

1.15

1.03

1.3

1.4

5.59

5.60

mmol/l

0.05

166

1397

Asthma, hospital admission 2, infections

173

1476

1.15

1.03

1.3

1.4

5.59

5.60

mmol/l

0.05

166

1397

Opioids

360

1694

1.10

1.03

1.4

5.64

5.48

mmol/l

1.94

338

1607

Benign neoplasm: Transverse colon

190

0.58

1.02

1.5

1.3

5.80

6.11

mmol/l

0.52

179

365

1.29

1.02

1.3

1.2

6.08

6.22

mmol/l

0.37

340

Visual disturbances

140

1203

1.16

1.01

1.4

5.59

5.67

mmol/l

0.26

135

1136

Disorders of eyelid, lacrimal system and orbit

256

1736

1.12

1.01

1.3

5.76

5.69

mmol/l

0.25

242

1637

Congenital malformations of the circulatory system

301

0.68

1.00

1.5

1.4

5.19

5.62

mmol/l

1.51

287

Renal tubulo-interstitial diseases

222

1861

0.89

1.00

1.3

1.4

6.00

5.58

mmol/l

2.72

209

1758

Solid cancers, helper endpoint

201

1346

0.88

0.99

1.2

1.3

5.95

5.75

mmol/l

1.66

191

1264

Insomnia

295

1937

1.11

0.99

1.3

1.4

5.44

5.55

mmol/l

0.81

279

1836

Disorders of vestibular function (Vertigo)

118

986

1.18

0.98

1.3

5.80

5.87

mmol/l

0.45

111

931

Coxibs

375

1.22

0.98

1.3

1.4

5.61

5.38

mmol/l

1.30

358

Raynaud syndrome

200

0.60

0.98

1.5

1.4

5.03

5.62

mmol/l

2.67

191

Polyarteritis nodosa and related conditions

2.18

0.98

1.4

1.3

5.24

6.70

mmol/l

—

Diseases of middle ear and mastoid

206

1490

1.13

0.97

1.4

5.24

5.41

mmol/l

1.60

195

1414

Dentofacial anomalies [including malocclusion]

253

1820

1.12

0.97

1.5

1.4

5.34

5.50

mmol/l

2.03

236

1726

Postprocedural disorders of nervous system

199

0.60

0.96

1.5

4.78

5.39

mmol/l

2.62

193

Use of levodopa decarboxylase inhibitor

211

0.62

0.96

1.2

5.92

6.20

mmol/l

0.55

198

Cervicalgia

442

1.27

0.96

1.3

5.69

5.80

mmol/l

0.36

417

Chronic mastoiditis

0.00

0.95

0.0

1.3

—

6.63

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

832

1.19

0.95

1.3

1.4

5.80

5.68

mmol/l

0.32

781

Inguinal hernia

134

769

1.17

0.94

1.2

1.3

5.85

5.86

mmol/l

0.04

126

727

Keratoconus

1.90

0.94

1.4

6.32

6.38

mmol/l

—

Congenital malformations of heart and great arteries

250

0.66

0.94

1.4

5.35

5.64

mmol/l

0.51

241

Injuries to the head

313

2119

0.91

0.94

1.3

1.4

5.61

5.57

mmol/l

0.24

290

2009

Non-small cell lung cancer

141

0.56

0.93

1.4

1.3

6.13

6.23

mmol/l

—

130

Oedema, not elsewhere classified

671

1.21

0.91

1.3

5.72

5.85

mmol/l

0.38

637

Other puerperal infections

331

1.30

0.90

1.8

1.6

4.90

5.12

mmol/l

1.24

316

Reimbursement for rheumatic diseases

128

1473

0.86

0.90

1.3

1.4

5.50

5.72

mmol/l

1.46

119

1388

Conjunctivitis

213

1990

0.89

0.90

1.5

1.4

5.46

5.51

mmol/l

0.26

201

1884

Unspecified privation

207

0.63

0.90

1.6

1.4

5.10

5.78

mmol/l

3.07

198

Haemorrhage from respiratory passages

524

1.22

0.89

1.3

6.04

5.89

mmol/l

0.50

502

Artificial joint re-operation

105

0.48

0.88

1.2

5.43

6.18

mmol/l

—

Papulosquamous disorders

105

895

1.17

0.87

1.3

5.78

5.81

mmol/l

0.15

842

Hyperaldosteronism

1.87

0.87

1.3

5.97

6.40

mmol/l

—

Tramadol

248

1371

1.11

0.87

1.3

1.4

5.79

5.65

mmol/l

1.39

228

1298

Injuries to the knee and lower leg

396

2023

1.09

0.86

1.4

5.66

5.56

mmol/l

0.90

373

1913

Diagnoses used for exclusion with ILD

459

0.76

0.85

1.2

1.3

5.92

5.98

mmol/l

0.09

436

Diseases of the skin and subcutaneous tissue

349

1602

1.09

0.85

1.4

5.59

5.58

mmol/l

0.05

331

1518

Other specific arthropathies, wide

1.94

0.84

1.0

1.3

5.48

6.53

mmol/l

—

L04AA Selective immunosuppressants

525

0.78

0.84

1.4

5.80

5.71

mmol/l

0.11

496

Malignant neoplasm

206

1362

0.89

0.84

1.2

1.3

5.93

5.75

mmol/l

1.71

196

1278

Abnormal weight loss

162

1.42

0.84

1.5

1.3

5.44

5.90

mmol/l

1.20

155

Mycoses

272

2149

1.10

0.84

1.3

1.4

5.61

5.57

mmol/l

0.19

257

2032

Superficial injury of thorax

310

1.29

0.82

1.4

1.3

5.79

5.69

mmol/l

0.16

294

Nonalcoholic fatty liver disease

180

1.39

0.81

1.4

5.67

5.90

mmol/l

0.51

171

Peritonsillar abscess

589

1.21

0.81

1.2

1.5

5.61

5.40

mmol/l

0.29

561

Benign neoplasm: Adrenal gland

130

1.46

0.80

1.1

1.3

6.32

6.14

mmol/l

0.16

124

Disorders of vitreous body

117

980

1.15

0.80

1.3

6.05

5.98

mmol/l

0.20

107

917

MS-disease / Multiple Sclerosis

188

0.64

0.79

1.3

1.5

5.61

5.49

mmol/l

0.12

181

Vitamin D deficiency

1.82

0.79

1.8

1.4

5.50

6.12

mmol/l

—

Carcinoma in situ of colon

0.00

0.79

0.0

1.2

—

6.90

—

Anxiety disorders

304

1940

1.09

0.79

1.4

5.69

5.54

mmol/l

1.01

286

1833

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.00

0.78

0.0

1.2

—

6.73

—

Viral encephalitis, not elsewhere classified/unspecified

0.00

0.78

0.0

1.3

—

6.74

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

1.57

0.78

1.5

1.1

6.48

6.80

mmol/l

0.27

Visual disturbances and blindness

144

1270

1.13

0.78

1.4

5.66

5.68

mmol/l

0.03

138

1196

Other or unspecified ileus, impaction or obstruction

304

0.72

0.78

1.3

6.32

6.11

mmol/l

0.31

286

Disorders of vitreous body and globe

120

1004

1.15

0.77

1.3

6.03

5.99

mmol/l

0.13

110

939

Somnolence

0.00

0.77

0.0

1.4

—

6.44

—

Coxarthrosis

113

645

1.16

0.77

1.2

5.98

6.07

mmol/l

0.46

104

610

Other and unspecified vascular occlusions

148

1.42

0.77

1.3

1.2

6.57

6.22

mmol/l

0.28

138

Presence of other functional implants

769

0.86

0.77

1.2

1.3

6.01

6.07

mmol/l

0.22

721

Malignant neoplasm of ovary, including Hilmo

125

0.56

0.77

1.4

1.3

5.82

5.84

mmol/l

—

119

Viral and other specified intestinal infections

858

0.84

0.77

1.4

1.5

5.29

5.22

mmol/l

0.19

824

Collagenous colitis

186

0.64

0.76

1.2

1.4

5.51

5.81

mmol/l

0.48

176

Coagulation defects, purpura and other haemorrhagic conditions

439

0.77

0.76

1.5

1.4

5.42

5.66

mmol/l

0.95

414

Infective bursitis

1.77

0.76

1.3

1.1

5.55

6.74

mmol/l

—

Hepatic failure, not elsewhere classified

1.70

0.75

1.1

1.3

6.10

6.33

mmol/l

—

Non-follicular lymphoma

149

1.41

0.75

1.4

1.3

5.99

6.16

mmol/l

0.29

142

Viral infections characterized by skin and mucous membrane lesions

273

2136

1.09

0.75

1.3

1.4

5.63

5.56

mmol/l

0.42

258

2022

Diarrhoea and gastroenteritis of presumed infectious origin

222

1813

1.10

0.74

1.3

1.4

5.67

5.54

mmol/l

0.65

206

1724

Benign neoplasm: Skin of ear and external auricular canal

1.67

0.74

1.6

1.3

6.11

6.25

mmol/l

—

Keratitis

101

874

1.16

0.73

1.3

1.4

5.60

5.70

mmol/l

0.26

827

Second line medication for Crohn's disease

135

1525

0.88

0.73

1.4

5.46

5.69

mmol/l

1.52

124

1439

Benign lipomatous neoplasm of other sites/unspecified

133

1.43

0.73

1.1

1.3

6.17

6.07

mmol/l

0.18

126

Acute tubulo-interstitial nephritis

155

1499

0.89

0.73

1.3

1.4

5.86

5.56

mmol/l

1.36

146

1414

Heart failure and coronary heart disease

447

1.19

0.73

1.2

6.16

6.18

mmol/l

0.05

425

Deep bite that required surgery

2.01

0.73

1.2

1.5

5.62

6.33

mmol/l

—

Other disorders of binocular movement

1.61

0.72

2.1

1.4

4.88

5.77

mmol/l

—

Other anxiety disorders

174

1353

1.11

0.72

1.5

1.4

5.58

5.32

mmol/l

1.26

169

1283

Other congenital malformations of ear

1.76

0.71

2.0

1.6

5.06

mmol/l

—

Other heart diseases, wide

304

1711

1.09

0.71

1.3

1.4

5.73

5.58

mmol/l

1.49

289

1626

Missing teeth due to accident, extraction or parodontitis

140

1170

1.13

0.71

1.3

6.11

5.89

mmol/l

1.20

130

1100

Amputation of ankle bones

1.93

0.70

1.0

1.2

8.14

6.94

mmol/l

—

Complications of procedures, not elsewhere classified

248

1877

1.09

0.70

1.3

1.4

5.71

5.65

mmol/l

0.28

236

1769

Other peripheral vascular diseases

170

0.65

0.70

1.6

1.4

5.33

5.79

mmol/l

0.90

162

Disorders of sclera, cornea, iris and ciliary body

155

1386

1.12

0.70

1.3

1.4

5.67

5.68

mmol/l

0.02

142

1314

Enteropathic arthropathies

1.71

0.70

1.6

1.3

5.14

5.73

mmol/l

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

137

1520

0.89

0.69

1.3

1.4

5.94

5.72

mmol/l

0.86

128

1432

Use of galantamine

1.51

0.69

1.2

6.42

6.37

mmol/l

0.04

Donors of organs and tissues

1.86

0.68

1.4

5.52

6.32

mmol/l

—

Disorders of optic nerve, not elsewhere classified

1.86

0.68

1.4

1.2

6.06

6.79

mmol/l

—

Other bursopathies

222

1.31

0.68

1.3

5.75

6.04

mmol/l

0.78

209

Other arthritis (FG)

732

1.16

0.67

1.2

1.3

5.52

5.75

mmol/l

1.56

695

Excessive attrition of teeth

185

1675

1.11

0.67

1.3

1.4

5.66

5.53

mmol/l

1.23

176

1588

Inflammatory diseases of the central nervous system

156

0.64

0.67

1.1

1.4

5.54

5.87

mmol/l

—

149

Venous complications and haemorrhoids in pregnancy

1.63

0.67

1.4

1.3

5.20

5.04

mmol/l

—

Diseases of the myoneural junction and muscle

205

1.32

0.67

1.3

6.04

5.94

mmol/l

0.12

194

Pedestrian injured in collision with car, pick-up truck or van

1.63

0.67

1.3

1.4

5.40

6.22

mmol/l

—

Disorders of conjunctiva

234

2049

0.92

0.66

1.5

1.4

5.49

5.54

mmol/l

0.32

221

1941

Other viral diseases, not elsewhere classified

720

1.16

0.66

1.4

5.34

5.43

mmol/l

0.38

682

Other specified and unspecified personality disorders

232

1.30

0.66

1.2

1.5

5.65

5.47

mmol/l

0.49

223

All kidney diseases

278

2057

0.92

0.65

1.3

1.4

5.91

5.54

mmol/l

3.14

260

1949

Neurotic, stress-related and somatoform disorders

299

1935

1.08

0.65

1.4

5.69

5.54

mmol/l

1.03

282

1828

Alzheimer’s disease (Atypical or mixed)

1.48

0.64

1.5

1.1

6.48

6.42

mmol/l

0.05

Acute nephritic syndrome

1.73

0.64

2.2

1.2

5.36

6.61

mmol/l

—

Paraplegia, diplegia of upper limbs

1.73

0.64

1.6

1.2

5.29

6.72

mmol/l

—

Implicit Sepsis

197

1352

1.10

0.64

1.3

5.88

5.77

mmol/l

0.66

180

1276

Myocardial infarction, strict

523

1.16

0.63

1.2

6.06

6.19

mmol/l

0.63

499

Colonic or urogenital fistula

598

1.17

0.63

1.5

1.3

5.81

5.78

mmol/l

0.12

570

Oter anti-inflammatory and antirheumatic agents, non-steroids

197

1.23

0.61

1.3

5.89

5.95

mmol/l

0.17

187

Selective serotonin reuptake inhibitors

332

1613

1.07

0.61

1.4

5.85

5.52

mmol/l

3.71

310

1539

Lesion of ulnar nerve

262

1.26

0.60

1.3

5.60

5.88

mmol/l

0.90

256

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

0.00

0.60

0.0

1.5

—

6.73

—

Abscess of lung

0.00

0.60

0.0

1.2

—

7.16

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

0.00

0.60

0.0

1.3

—

5.88

—

Secondary malignant neoplasm of other and unspecified sites

0.00

0.60

0.0

1.3

—

6.86

—

Other diseases of pleura

685

0.86

0.60

1.3

1.2

6.19

6.08

mmol/l

0.33

645

Iliotibial band syndrome

0.00

0.60

0.0

1.6

—

5.87

—

Hereditary retinal dystrophy

0.00

0.60

0.0

1.4

—

6.70

—

Other and unspecified haemorrhagic conditions

0.00

0.60

0.0

1.2

—

6.90

—

Malignant neoplasm, wide definition for exclusion

225

1435

0.92

0.60

1.2

1.3

5.90

5.72

mmol/l

1.64

214

1349

Other antidepressants

337

1609

1.07

0.60

1.3

1.4

5.87

5.52

mmol/l

3.95

315

1536

Urticaria and erythema

1068

0.88

0.60

1.3

1.4

5.36

5.53

mmol/l

1.11

1008

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

275

1631

1.08

0.59

1.3

5.77

mmol/l

0.02

260

1534

Viral and other specified intestinal infections

625

0.84

0.59

1.4

1.5

5.32

5.19

mmol/l

0.29

603

Carcinoma in situ of breast, other/unspecified

0.00

0.59

0.0

1.2

—

5.66

—

Other degenerative diseases of the basal ganglia

0.00

0.59

0.0

1.2

—

7.25

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.00

0.59

0.0

1.2

—

6.94

—

Motor neuron disease

0.00

0.59

0.0

1.2

—

7.24

—

Other noninfective gastroenteritis and colitis

552

0.83

0.59

1.3

1.4

5.47

5.68

mmol/l

0.61

521

Other disorders of fluid, electrolyte and acid-base balance

485

1.18

0.59

1.2

1.3

6.30

5.99

mmol/l

0.87

460

130

1274

0.90

0.58

1.3

1.4

5.93

5.70

mmol/l

1.29

123

1206

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

0.00

0.58

0.0

1.3

—

6.58

—

Scleritis

0.00

0.58

0.0

1.2

—

6.67

—

Other protozoal intestinal diseases

0.00

0.58

0.0

1.5

—

6.28

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

0.00

0.58

0.0

1.2

—

7.00

—

Orchitis and epididymitis

112

0.62

0.58

1.3

5.89

6.47

mmol/l

—

104

Failed attempted abortion

1.72

0.58

1.3

1.4

4.82

5.10

mmol/l

—

Temporomandibular joint disorders, including avohilmo

167

1499

1.10

0.57

1.4

5.25

5.38

mmol/l

1.21

157

1427

Acute appendicitis, no complications

177

1610

1.09

0.57

1.5

1.4

5.41

5.60

mmol/l

1.55

166

1527

Benign neoplasm: Anus and anal canal

1.67

0.56

1.0

1.2

5.42

6.57

mmol/l

—

Other and unspecified epidermal thickening

1.63

0.55

1.3

1.5

5.28

6.27

mmol/l

—

Condition for Implicit Sepsis (Organ dysfunction codes)

242

1582

1.08

0.55

1.3

1.4

5.83

5.71

mmol/l

0.89

221

1495

Myocardial infarction

570

1.14

0.55

1.2

6.09

6.16

mmol/l

0.23

545

Dizziness and giddiness

213

1557

1.08

0.54

1.3

1.4

5.63

5.71

mmol/l

0.48

193

1478

Dermatitis due to substances taken internally

122

0.65

0.54

1.1

1.5

5.16

5.79

mmol/l

—

116

Polyarthropathies

197

1182

1.09

0.54

1.2

1.4

5.69

5.65

mmol/l

0.24

179

1122

Unspecified abortion

1.42

0.54

1.3

5.83

5.51

mmol/l

0.68

Other disorders of skin and subcutaneous tissue

156

1518

0.91

0.53

1.2

1.4

5.82

5.76

mmol/l

0.19

149

1427

Allergic asthma (mode), excluding more controls

687

1.14

0.53

1.5

1.4

5.45

5.37

mmol/l

0.29

662

Malignant melanoma of skin

193

0.72

0.53

1.3

6.00

6.08

mmol/l

0.14

181

Fall on same level involving ice and snow

159

1452

1.10

0.53

1.2

1.4

5.83

5.68

mmol/l

1.02

151

1373

Endometriosis

122

795

0.90

0.53

1.4

1.5

5.38

5.23

mmol/l

1.22

111

765

Stroke, including SAH

127

830

1.11

0.53

1.3

6.05

6.06

mmol/l

0.05

118

784

Other necrotizing vasculopathies

108

1.39

0.53

1.1

1.3

5.70

6.15

mmol/l

0.90

103

Hyperprolactinaemia

1.43

0.53

1.5

5.55

5.61

mmol/l

0.06

131

1176

1.11

0.52

1.4

5.50

5.54

mmol/l

0.25

126

1112

Bronchitis, not specified as acute or chronic

143

1.33

0.52

1.4

1.3

5.70

5.93

mmol/l

0.45

137

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

100

1.40

0.51

1.3

5.97

5.93

mmol/l

0.05

Other specified disorders of muscle

1.50

0.51

1.5

1.4

5.65

6.39

mmol/l

—

Psoriasis (vulgaris), strict definition

1.50

0.51

1.7

1.4

5.60

6.36

mmol/l

—

ILD, hospital admissions 3, with pneumonia sepsis

134

0.67

0.51

1.4

1.3

6.34

6.18

mmol/l

—

125

Abdominal aortic aneurysm (AAA)

133

0.67

0.51

1.1

1.2

6.47

6.39

mmol/l

—

124

1238

0.90

0.51

1.3

1.4

5.93

5.71

mmol/l

1.13

117

1173

Necrosis of pulp, including avohilmo

181

1662

1.09

0.51

1.3

1.4

5.66

5.58

mmol/l

0.27

169

1578

Depression or dysthymia

214

1092

1.08

0.51

1.4

5.76

5.54

mmol/l

2.18

199

1033

Coronary artery bypass grafting

254

1.20

0.50

1.2

6.46

6.28

mmol/l

0.33

244

Venous thromboembolism

1068

0.89

0.50

1.3

5.73

5.91

mmol/l

1.05

1006

ILD, hospital admission 2, with pulmonary infections

145

0.69

0.50

1.4

1.3

6.29

6.12

mmol/l

—

136

Other coagulation defects

168

0.71

0.50

1.4

5.42

5.63

mmol/l

0.29

163

Any gastric operation

305

1433

1.07

0.50

1.5

1.4

5.63

5.43

mmol/l

1.12

289

1363

GASTRO-related operations

305

1433

1.07

0.50

1.5

1.4

5.63

5.43

mmol/l

1.12

289

1363

Post-traumatic wound infection, not elsewhere classified

1.47

0.50

1.0

1.4

6.12

6.33

mmol/l

—

Volvulus

1.47

0.50

1.0

1.4

6.38

6.46

mmol/l

—

Benign paroxysmal vertigo

603

1.15

0.50

1.3

5.81

5.89

mmol/l

0.35

565

Heart failure, not strict

173

1079

1.09

0.50

1.2

1.3

6.27

5.93

mmol/l

1.91

156

1014

Injuries involving multiple body regions

1.50

0.49

1.2

1.4

6.40

5.95

mmol/l

—

Melanocytic naevi, other sites/unspecified

171

1.29

0.49

1.3

1.4

5.47

5.77

mmol/l

0.60

165

Autoimmune diseases

371

1780

1.06

0.49

1.4

5.74

5.52

mmol/l

1.44

346

1695

Obsessive-compulsive disorder

235

0.76

0.49

1.3

1.6

5.51

5.13

mmol/l

0.86

228

Coxarthrosis [arthrosis of hip](FG)

117

743

1.11

0.49

1.2

5.98

6.08

mmol/l

0.55

108

701

Implicit bacterial Sepsis

635

1.13

0.48

1.2

1.3

6.10

6.01

mmol/l

0.25

598

L04AX Other immunosuppressants

135

1478

0.91

0.48

1.4

5.46

5.71

mmol/l

1.68

124

1396

Superficial injuries involving multiple body regions

1.53

0.48

1.1

1.4

6.94

6.16

mmol/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glucose [Moles/volume] in Serum or Plasma --baseline

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS